Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
34,100
Employees34,100
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
34,100
Employees34,100

BMY Key Statistics

Market cap
99.75B
Market cap99.75B
Price-Earnings ratio
16.57
Price-Earnings ratio16.57
Dividend yield
5.05%
Dividend yield5.05%
Average volume
14.29M
Average volume14.29M
High today
$49.99
High today$49.99
Low today
$48.48
Low today$48.48
Open price
$49.42
Open price$49.42
Volume
14.50M
Volume14.50M
52 Week high
$63.33
52 Week high$63.33
52 Week low
$42.52
52 Week low$42.52

Stock Snapshot

As of today, Bristol-Myers Squibb(BMY) shares are valued at $48.75. The company's market cap stands at 99.75B, with a P/E ratio of 16.57 and a dividend yield of 5.1%.

As of 2025-11-13, Bristol-Myers Squibb(BMY) stock has fluctuated between $48.48 and $49.99. The current price stands at $48.75, placing the stock +0.6% above today's low and -2.5% off the high.

The Bristol-Myers Squibb(BMY)'s current trading volume is 14.5M, compared to an average daily volume of 14.29M.

During the past year, Bristol-Myers Squibb(BMY) stock moved between $42.52 at its lowest and $63.33 at its peak.

During the past year, Bristol-Myers Squibb(BMY) stock moved between $42.52 at its lowest and $63.33 at its peak.

BMY News

Simply Wall St 3d
Assessing Bristol-Myers Squibb's Valuation Following Recent Share Price Uptick

Bristol-Myers Squibb (BMY) shares have seen some movement recently, with the stock notching a modest gain over the past month. Investors are sizing up current v...

Assessing Bristol-Myers Squibb's Valuation Following Recent Share Price Uptick
TipRanks 3d
Bristol-Myers Squibb Completes €5 Billion Note Offering

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...

Nasdaq 4d
Validea Detailed Fundamental Analysis - BMY

Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our Low PE Investor m...

Validea Detailed Fundamental Analysis - BMY

Analyst ratings

70%

of 30 ratings
Buy
26.7%
Hold
70%
Sell
3.3%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.